In-depth characterization of heart-brain communication in critically ill patients with severe acute respiratory failure is attracting significant interest in the COronaVIrus Disease 19 (COVID-19) pandemic era during intensive care unit (ICU) stay and after ICU or hospital discharge. Emerging research has provided new insights into pathogenic role of the deregulation of the heart-brain axis (HBA), a bidirectional flow of information, in leading to severe multiorgan disease syndrome (MODS) in patients with confirmed infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Noteworthy, HBA dysfunction may worsen the outcome of the COVID-19 patients. In this review, we discuss the critical role HBA plays in both promoting and limiting MODS in COVID-19. We also highlight the role of HBA as new target for novel therapeutic strategies in COVID-19 in order to open new translational frontiers of care. This is a translational perspective from the Italian Society of Cardiovascular Researches.

Understanding the heart-brain axis response in COVID-19 patients: A suggestive perspective for therapeutic development

Gerbino A.;Ghigo A.;Iaccarino G.;Moccia F.;Munaron L.;Pagliaro P.;Penna C.;Tocchetti C. G.;Angelone T.
2021-01-01

Abstract

In-depth characterization of heart-brain communication in critically ill patients with severe acute respiratory failure is attracting significant interest in the COronaVIrus Disease 19 (COVID-19) pandemic era during intensive care unit (ICU) stay and after ICU or hospital discharge. Emerging research has provided new insights into pathogenic role of the deregulation of the heart-brain axis (HBA), a bidirectional flow of information, in leading to severe multiorgan disease syndrome (MODS) in patients with confirmed infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Noteworthy, HBA dysfunction may worsen the outcome of the COVID-19 patients. In this review, we discuss the critical role HBA plays in both promoting and limiting MODS in COVID-19. We also highlight the role of HBA as new target for novel therapeutic strategies in COVID-19 in order to open new translational frontiers of care. This is a translational perspective from the Italian Society of Cardiovascular Researches.
2021
168
105581
105592
COVID-19; Heart-brain axis; Multiorgan disease syndrome; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antiviral Agents; Brain; Brain Diseases; COVID-19; Critical Care; Critical Illness; Dietary Supplements; Functional Food; Heart; Heart Diseases; Humans; Inflammation Mediators; Microvessels; Multiple Organ Failure; SARS-CoV-2
Lionetti V.; Bollini S.; Coppini R.; Gerbino A.; Ghigo A.; Iaccarino G.; Madonna R.; Mangiacapra F.; Miragoli M.; Moccia F.; Munaron L.; Pagliaro P.; Parenti A.; Pasqua T.; Penna C.; Quaini F.; Rocca C.; Samaja M.; Sartiani L.; Soda T.; Tocchetti C.G.; Angelone T.
File in questo prodotto:
File Dimensione Formato  
2021_Understanding_covid_physiol res.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 3.23 MB
Formato Adobe PDF
3.23 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1881402
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 21
social impact